- Home
- MVO vs TELA Comparison
MVO vs TELA Comparison
Compare MVO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- TELA
- Stock Information
- Founded
- MVO 2006
- TELA 2012
- Country
- MVO United States
- TELA United States
- Employees
- MVO N/A
- TELA N/A
- Industry
- MVO Oil & Gas Production
- TELA Medical/Dental Instruments
- Sector
- MVO Energy
- TELA Health Care
- Exchange
- MVO Nasdaq
- TELA Nasdaq
- Market Cap
- MVO 67.6M
- TELA 80.7M
- IPO Year
- MVO N/A
- TELA 2019
- Fundamental
- Price
- MVO $5.91
- TELA $1.92
- Analyst Decision
- MVO
- TELA Strong Buy
- Analyst Count
- MVO 0
- TELA 4
- Target Price
- MVO N/A
- TELA $6.00
- AVG Volume (30 Days)
- MVO 55.1K
- TELA 58.2K
- Earning Date
- MVO 01-01-0001
- TELA 08-11-2025
- Dividend Yield
- MVO 17.46%
- TELA N/A
- EPS Growth
- MVO N/A
- TELA N/A
- EPS
- MVO 1.46
- TELA N/A
- Revenue
- MVO N/A
- TELA $71,217,000.00
- Revenue This Year
- MVO N/A
- TELA $26.67
- Revenue Next Year
- MVO N/A
- TELA $22.63
- P/E Ratio
- MVO $7.29
- TELA N/A
- Revenue Growth
- MVO N/A
- TELA 12.78
- 52 Week Low
- MVO $8.85
- TELA $0.86
- 52 Week High
- MVO $13.95
- TELA $4.70
- Technical
- Relative Strength Index (RSI)
- MVO 51.16
- TELA 51.12
- Support Level
- MVO $5.53
- TELA $1.60
- Resistance Level
- MVO $6.13
- TELA $2.19
- Average True Range (ATR)
- MVO 0.18
- TELA 0.18
- MACD
- MVO 0.01
- TELA -0.03
- Stochastic Oscillator
- MVO 62.30
- TELA 53.49
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.